These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2852918)

  • 1. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment.
    Fennie EH; Lie YS; Low MA; Gribling P; Anderson KP
    Antiviral Res; 1988 Nov; 10(1-3):27-39. PubMed ID: 2852918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tumor necrosis factor-alpha treatment on mortality in murine cytomegalovirus-infected mice.
    Anderson KP; Lie YS; Low MA; Fennie EH
    Antiviral Res; 1993 Aug; 21(4):343-55. PubMed ID: 8215304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon.
    Heise MT; Pollock JL; O'Guin A; Barkon ML; Bormley S; Virgin HW
    Virology; 1998 Feb; 241(2):331-44. PubMed ID: 9499808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma.
    Schut RL; Gekker G; Hu S; Chao CC; Pomeroy C; Jordan MC; Peterson PK
    J Infect Dis; 1994 May; 169(5):1092-6. PubMed ID: 8169398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.
    Bartlett EJ; Cull VS; Brekalo NL; Lenzo JC; James CM
    Immunol Cell Biol; 2002 Oct; 80(5):425-35. PubMed ID: 12225378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interferon-gamma in murine cytomegalovirus infection.
    Pomeroy C; Delong D; Clabots C; Riciputi P; Filice GA
    J Lab Clin Med; 1998 Aug; 132(2):124-33. PubMed ID: 9708573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection.
    Shanley JD; Pesanti EL
    J Infect Dis; 1985 Mar; 151(3):454-8. PubMed ID: 2982963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection.
    Allan JE; Shellam GR
    J Gen Virol; 1985 May; 66 ( Pt 5)():1105-12. PubMed ID: 2582082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma.
    Dix RD; Cousins SW
    Curr Eye Res; 2004; 29(2-3):173-80. PubMed ID: 15512964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription.
    Gribaudo G; Ravaglia S; Caliendo A; Cavallo R; Gariglio M; Martinotti MG; Landolfo S
    Virology; 1993 Nov; 197(1):303-11. PubMed ID: 8212566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist.
    Le-Trilling VTK; Wohlgemuth K; Rückborn MU; Jagnjic A; Maaßen F; Timmer L; Katschinski B; Trilling M
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the production of murine cytomegalovirus and interferon in macrophages.
    Yamaguchi T; Shinagawa Y; Pollard RB
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():2961-71. PubMed ID: 2462012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice.
    Bale JF; O'Neil ME
    J Virol; 1989 Jun; 63(6):2667-73. PubMed ID: 2542580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine model for immunoprophylaxis of cytomegalovirus infection. I. Efficacy of immunization.
    Minamishima Y; Eizuru Y; Yoshida A; Fukunishi R
    Microbiol Immunol; 1978; 22(11):693-700. PubMed ID: 85239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression.
    Holzki JK; Dağ F; Dekhtiarenko I; Rand U; Casalegno-Garduño R; Trittel S; May T; Riese P; Čičin-Šain L
    J Virol; 2015 Oct; 89(19):9886-95. PubMed ID: 26202227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.
    Quinnan GV; Manischewitz JF
    J Virol; 1987 Jun; 61(6):1875-81. PubMed ID: 3033318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyadenylic: polyuridylic acid-induced determinants of host resistance to cytomegalovirus and their potentiation by hyperthermia.
    Lee BK; Mohrman M; Odean MJ; Johnson AG; Morin A; Deschamps de Paillette E
    J Immunother (1991); 1992 Aug; 12(2):105-14. PubMed ID: 1324000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.